Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Clopidogrel
Plavix
Routinely available
SMC (88/04)
01/11/2004

Indication

Prevention of atherothrombotic events in acute coronary syndrome. See link to SMC advice for full details of restriction.

Prevention of atherothrombotic events in acute coronary syndrome. See link to SMC advice for full details of restriction.

Therapeutic Area

Cardiovascular system

Status Description

Routinely available in line with national guidance

Formulation

Tablets

Comments

November 2004 - Included in the Adult Formulary. August 2006 - Prescribing guideline states the criteria by which a patient would qualify for this treatment; the appropriate dose; and the duration of treatment. June 2019 (as per LJF) - Routinely available in line with national guidance. Included in the LJF.

Link to Advice

88/04

Advice Published

08/03/2004

SMC Submission Type

Full

SMC Status

Restricted